Multinational pharmaceutical companies betting everything on development of new drugs
While growth of multinational pharmaceutical companies in the domestic market has lost in speed, they tend to focus on development of new drugs.
One of the outstanding companies in the trend is MSD Korea. Last year, the company, staring with approval of the COX-2 type anti-inflammatory agent ‘Ar...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
